LGALS1 and neoplasm: While Galectin-1 (Gal-1) has been extensively reported to regulate not only tumor-intrinsic properties but also the broader tumor microenvironment, including immunity, the experimental design of this study is primarily focused on evaluating the endogenous tumor-related effects of Gal-1.